IHH Healthcare’s planned purchase of Indian hospital group Fortis Healthcare could be derailed depending on how a local court rules in response to Japanese drugmaker Daiichi Sankyo’s protest.
Malaysia-based IHH said last month it will acquire Fortis for up to $1.1 billion. The plan is to acquire a majority stake through a combination of private placement and tender offer by the end of 2018.